Vibha Jawa

Vibha Jawa

Company: Merck

Job title: Director and Lead, Predictive and Clinical Immunogenicity Strategy


Deep Dive: Evaluating Immunogenicity in the Eye: Best Approaches & Practices 2:30 pm

There has been much debate over the relative ‘immunoprivilege’ of the eye compared to other organs being targeted by gene therapy. It’s clear from a regulatory perspective that immune response triggered by administration of gene therapies is a key consideration, and so working to better predict, monitor and mitigate immune response in the eye will…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.